{"id":9111,"date":"2019-05-27T11:45:00","date_gmt":"2019-05-27T09:45:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/idag-den-27-maj-ar-sista-dag-for-handel-i-irlabs-aktie-fore-aktiesplit\/"},"modified":"2019-05-27T11:45:00","modified_gmt":"2019-05-27T09:45:00","slug":"idag-den-27-maj-ar-sista-dag-for-handel-i-irlabs-aktie-fore-aktiesplit","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/idag-den-27-maj-ar-sista-dag-for-handel-i-irlabs-aktie-fore-aktiesplit\/","title":{"rendered":"Idag, den 27 maj, \u00e4r sista dag f\u00f6r handel i IRLAB:s aktie f\u00f6re aktiesplit"},"content":{"rendered":"

[mfn_before_post]<\/p>\n

IRLAB meddelar att idag, m\u00e5ndag den 27 maj 2019, \u00e4r sista dagen f\u00f6r handel i bolagets aktie f\u00f6re den beslutade uppdelningen av bolagets aktie. Imorgon, tisdag den 28 maj 2019, \u00e4r f\u00f6rsta dagen f\u00f6r handel efter uppdelningen. Detta inneb\u00e4r att aktiekursen kommer att \u00e5terspegla effekten av uppdelningen fr\u00e5n och med den 28 maj 2019.<\/strong><\/div>\n

Villkoren f\u00f6r aktiespliten \u00e4r en 5:1 uppdelning, d\u00e4r varje nuvarande aktie (1) delas upp i fem (5) aktier av samma slag. F\u00f6r mer information ang\u00e5ende aktiespliten h\u00e4nvisas till tidigare pressmeddelande \u201dIRLAB meddelar avst\u00e4mningsdag f\u00f6r aktiesplit\u201d publicerat den 17 maj 2019. Genomf\u00f6randet av en aktiesplit beslutades vid IRLAB Therapeutics AB:s \u00e5rsst\u00e4mma den 25 april 2019.<\/span><\/p>\n

Uppdelningen av bolagets aktier sker automatiskt via Euroclear Sweden AB och aktie\u00e4gare beh\u00f6ver inte vidta n\u00e5gra \u00e5tg\u00e4rder.<\/span><\/p>\n

\n

F\u00f6r vidare information<\/strong><\/p>\n

Nicholas Waters, VD\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
Tel: +46 730 75 77 01\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0\u00a0
E-post: nicholas.waters@irlab.se<\/a><\/p>\n

Viktor Siewertz, CFO\u00a0
Tel: +46 727 10 70 70\u00a0
E-post: viktor.siewertz@irlab.se<\/a><\/p>\n<\/div>\n

\n

Om IRLAB<\/strong><\/p>\n

IRLAB \u00e4r ett svenskt biotechbolag fokuserat p\u00e5 Parkinsons sjukdom. Bolagets kliniska Fas II-kandidater, IRL752 och IRL790, \u00e4mnar behandla n\u00e5gra av de sv\u00e5raste symtomen relaterade till Parkinsons sjukdom: ofrivilliga r\u00f6relser (LIDs), psykos och demens. Genom den propriet\u00e4ra forskningsplattformen ISP (Integrative Screening Process) uppt\u00e4cker och utvecklar IRLAB l\u00e4kemedelskandidater f\u00f6r sjukdomar relaterade till det centrala nervsystemet (CNS) d\u00e4r stora v\u00e4xande medicinska behov f\u00f6religger. F\u00f6rutom de kliniska kandidaterna har ISP-plattformen dessutom genererat flera CNS-program som nu \u00e4r i preklinisk fas. IRLAB:s Certified Adviser p\u00e5 Nasdaq First North \u00e4r FNCA Sweden AB, info@fnca.se, 08-528 00 399. Mer information p\u00e5 www.irlab.se<\/a>.<\/p>\n<\/div>\n

[mfn_after_post]<\/p>\n","protected":false},"excerpt":{"rendered":"

IRLAB meddelar att idag, m\u00e5ndag den 27 maj 2019, \u00e4r sista dagen f\u00f6r handel i bolagets aktie f\u00f6re den beslutade uppdelningen av bolagets aktie. Imorgon, tisdag den 28 maj 2019, \u00e4r f\u00f6rsta dagen f\u00f6r handel efter uppdelningen. Detta inneb\u00e4r att aktiekursen kommer att \u00e5terspegla effekten av uppdelningen fr\u00e5n och med den 28 maj 2019.<\/p>\n","protected":false},"template":"","class_list":["post-9111","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ca-shares_sv","mfn-news-tag-mfn-ca_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn-regulatory-lhfi_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ca-shares-rights_sv","mfn-news-tag-mfn-regulatory_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nIdag, den 27 maj, \u00e4r sista dag f\u00f6r handel i IRLAB:s aktie f\u00f6re aktiesplit - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/mfn_news\/idag-den-27-maj-ar-sista-dag-for-handel-i-irlabs-aktie-fore-aktiesplit\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Idag, den 27 maj, \u00e4r sista dag f\u00f6r handel i IRLAB:s aktie f\u00f6re aktiesplit - IRLAB\" \/>\n<meta property=\"og:description\" content=\"IRLAB meddelar att idag, m\u00e5ndag den 27 maj 2019, \u00e4r sista dagen f\u00f6r handel i bolagets aktie f\u00f6re den beslutade uppdelningen av bolagets aktie. Imorgon, tisdag den 28 maj 2019, \u00e4r f\u00f6rsta dagen f\u00f6r handel efter uppdelningen. Detta inneb\u00e4r att aktiekursen kommer att \u00e5terspegla effekten av uppdelningen fr\u00e5n och med den 28 maj 2019.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/mfn_news\/idag-den-27-maj-ar-sista-dag-for-handel-i-irlabs-aktie-fore-aktiesplit\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/idag-den-27-maj-ar-sista-dag-for-handel-i-irlabs-aktie-fore-aktiesplit\/\",\"url\":\"https:\/\/irlab.se\/mfn_news\/idag-den-27-maj-ar-sista-dag-for-handel-i-irlabs-aktie-fore-aktiesplit\/\",\"name\":\"Idag, den 27 maj, \u00e4r sista dag f\u00f6r handel i IRLAB:s aktie f\u00f6re aktiesplit - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2019-05-27T09:45:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/mfn_news\/idag-den-27-maj-ar-sista-dag-for-handel-i-irlabs-aktie-fore-aktiesplit\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/mfn_news\/idag-den-27-maj-ar-sista-dag-for-handel-i-irlabs-aktie-fore-aktiesplit\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/idag-den-27-maj-ar-sista-dag-for-handel-i-irlabs-aktie-fore-aktiesplit\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Idag, den 27 maj, \u00e4r sista dag f\u00f6r handel i IRLAB:s aktie f\u00f6re aktiesplit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson's disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Idag, den 27 maj, \u00e4r sista dag f\u00f6r handel i IRLAB:s aktie f\u00f6re aktiesplit - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/mfn_news\/idag-den-27-maj-ar-sista-dag-for-handel-i-irlabs-aktie-fore-aktiesplit\/","og_locale":"sv_SE","og_type":"article","og_title":"Idag, den 27 maj, \u00e4r sista dag f\u00f6r handel i IRLAB:s aktie f\u00f6re aktiesplit - IRLAB","og_description":"IRLAB meddelar att idag, m\u00e5ndag den 27 maj 2019, \u00e4r sista dagen f\u00f6r handel i bolagets aktie f\u00f6re den beslutade uppdelningen av bolagets aktie. Imorgon, tisdag den 28 maj 2019, \u00e4r f\u00f6rsta dagen f\u00f6r handel efter uppdelningen. Detta inneb\u00e4r att aktiekursen kommer att \u00e5terspegla effekten av uppdelningen fr\u00e5n och med den 28 maj 2019.","og_url":"https:\/\/irlab.se\/mfn_news\/idag-den-27-maj-ar-sista-dag-for-handel-i-irlabs-aktie-fore-aktiesplit\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/mfn_news\/idag-den-27-maj-ar-sista-dag-for-handel-i-irlabs-aktie-fore-aktiesplit\/","url":"https:\/\/irlab.se\/mfn_news\/idag-den-27-maj-ar-sista-dag-for-handel-i-irlabs-aktie-fore-aktiesplit\/","name":"Idag, den 27 maj, \u00e4r sista dag f\u00f6r handel i IRLAB:s aktie f\u00f6re aktiesplit - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2019-05-27T09:45:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/mfn_news\/idag-den-27-maj-ar-sista-dag-for-handel-i-irlabs-aktie-fore-aktiesplit\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/mfn_news\/idag-den-27-maj-ar-sista-dag-for-handel-i-irlabs-aktie-fore-aktiesplit\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/mfn_news\/idag-den-27-maj-ar-sista-dag-for-handel-i-irlabs-aktie-fore-aktiesplit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"Idag, den 27 maj, \u00e4r sista dag f\u00f6r handel i IRLAB:s aktie f\u00f6re aktiesplit"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson's disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/9111","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=9111"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}